1. It is, however, hoped that with greater use of AZT by HIV-positive pregnant women, the number of new cases in newborns can be reduced.
  2. Morbidity and Mortality Weekly Report. U.S. Department of Health and Human Services, Public Health Service. November 24, 1995, vol. 44, No. 46.
  3. Hellinger, F. The Lifetime Cost of Treating a Person with HIV. AHCPR Publication Number 93-0080, 1993.
  4. Centers for Disease Control and Prevention, Division of TB Elimination, 1995.
  5. The accelerated approval regulation permits companies to seek approval of drugs for serious or life-threatening diseases when the drug provides meaningful therapeutic benefit over existing therapies. Under these procedures, the FDA may approve drugs based on surrogate endpoints, such as CD4+ cell counts that reasonably predict that a drug provides clinical benefit. The company is then required to confirm this clinical benefit through additional human studies to be completed after marketing approval. The accelerated approval regulation provides for removal of the drug from the market if further studies do not confirm the clinical benefit of the therapy.
  6. Alan B. Stone, and Penelope J. Hitchcock. Vaginal Microbicides for Preventing the Transmission of HIV. AIDS 1994, 8 (suppl 1):S285-S293.
  7. Agency for Health Care Policy and Research: Data from the Screener Questionnaire, AIDS Cost and Services Utilization Survey. 1991.
  8. Housing and the HIV/AIDS Epidemic: Recommendations for Action. National Commission on AIDS. Washington, D.C. July 1992.
  9. HIV/AIDS Policy Guidance. U.S. Agency for International Development. September 1995.
  10. Until recently, the United Nations' response to HIV/AIDS was carried out primarily by the World Health Organization's Global Programme on AIDS. On January 1, 1996 the U.N. launched UNAIDS, co-sponsored by six U.N. agencies to strengthen coordination and focus support for HIV/AIDS activities at the global and country levels. UNAIDS has established three mutually reinforcing roles: to be a major source of policy development and research; provide technical support; and be an advocate for comprehensive, multi-sectoral responses to the pandemic.
  11. Douglas S. Paauw, Marjorie D. Wenrich, J. Randall Curtis, Jan D. Carline, Paul G. Ramsey. Ability of Primary Care Physicians to Recognize Physical Finding Associated with HIV Infection. JAMA. 1995; 274:1380-1382.
  12. Colombotos, J., Messeri, P., McConnell, M.B., et al. Physicians, Nurses, and AIDS: Findings From a National Study. Rockville, MD: Agency for Health Care Policy and Research, 1995. Grant No. HS06359. (NTIS Publication PB95-129185)



Go to White House Home Page
Go to ONAP Home Page
Go to White House Help Page
White House Home
ONAP Home Page
White House Help